Latest / Tulsa News Today | 2 Min News | The Daily News Now!
Moderna and Merck’s Melanoma Breakthrough | Tulsa News
Moderna and Merck just dropped a game-changing update: their personalized mRNA cancer vaccine, paired with Keytruda, slashed melanoma recurrence risk by 44%—a landmark win that’s sparking hope across oncology. The trial, involving 157 patients, showed the combo is not only highly effective but also well-tolerated, with no new side effects. This breakthrough isn’t limited to melanoma—researchers are already adapting the tech for bladder and colorectal cancers, especially for patients who didn’t respond to first-line treatments. Doctors are calling it a “huge win,” and the science is proving…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.